Nabumetone

Nabumetone is a methyl ketone that is 2-butanone in which one of the methyl hydrogens at position 4 is replaced by a 6-methoxy-2-naphthyl group. A prodrug that is converted to the active metabolite, 6-methoxy-2-naphthylacetic acid, following oral administration. It is shown to have a slightly lower risk of gastrointestinal side effects than most other non-steroidal anti-inflammatory drugs. Among its listed roles, it functions as a non-steroidal anti-inflammatory drug, a non-narcotic analgesic, a cyclooxygenase 2 inhibitor and a prodrug. It is a methoxynaphthalene and a methyl ketone. It is grouped under the following drug class(es): Cyclooxygenase‑1 (COX‑1) Inhibitors, Cyclooxygenase‑2 (COX‑2) Inhibitors and Non-Steroidal Anti-Inflammatory Drugs (NSAID). Its therapeutic use is listed as analgesics, anti-inflammatories, antipyretics and osteoarthritis agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Relafen, 4-(6-methoxynaphthalen-2-yl)butan-2-one and Nabumetona. Its PubChem CID is 4409.

CAS No 42924-53-8
Molecular Formula C15H16O2
Molecular Weight 228.29 g/mol
Synonyms 4-(6-methoxynaphthalen-2-yl)butan-2-one

Frequently Asked Questions